Evaluation of thyroid dysfunction and autoimmunity in gestational diabetes mellitus and its relationship with postpartum thyroiditis

Diabetic Medicine

Volumn 32, Issue 2, 2015, Pages 206-212

  Maleki, N ^a   Tavosi, Z ^a  

^a BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

LONG ACTING INSULIN; SHORT ACTING INSULIN; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; AUTOANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DELIVERY; FEMALE; FIRST DEGREE RELATIVE; FOLLOW UP; GESTATION PERIOD; GOITER; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MEDICAL HISTORY; POSTPARTUM THYROIDITIS; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PUERPERIUM; SPONTANEOUS ABORTION; THYROID DISEASE; THYROID FUNCTION TEST; BLOOD; DIFFERENTIAL DIAGNOSIS; HOSPITAL; IMMUNOLOGY; IRAN; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; PROSPECTIVE STUDY; PUBLIC HOSPITAL; RISK; THYROID GLAND; THYROIDITIS; THYROIDITIS, AUTOIMMUNE; UNIVERSITY HOSPITAL; YOUNG ADULT;

ADULT; AUTOANTIBODIES; AUTOIMMUNITY; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, PUBLIC; HOSPITALS, UNIVERSITY; HOSPITALS, URBAN; HUMANS; IRAN; POSTPARTUM PERIOD; PREGNANCY; PREVALENCE; PROSPECTIVE STUDIES; RISK; THYROID GLAND; THYROIDITIS; THYROIDITIS, AUTOIMMUNE; YOUNG ADULT;

EID: 84921342636     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12580     Document Type: Article

References (39)

1. Metzger B, Buchanan T, Coustan D, De Leiva A, Dunger D, Hadden D et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007; 30: S251-S260.
2. National Institute for Health and Care Excellence. Antenatal Care: Routine Care for the Healthy Pregnant Woman. Clinical guideline no. 62. London: National Institute for Health and Care Excellence/National Collaborating Centre for Women's and Children's Health, 2008.
3. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR et al. HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002.
4. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med 2004; 21: 103-113.
5. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 24: 2477-2486.
6. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009; 361: 1339-1348.
7. ADA. American Diabetes Association position statement: gestational diabetes mellitus. Diabetes Care 2004; 27: S88-S90.
8. Tutino GE, Tam WH, Yang X, Chan JC, Lao TT, Ma RC. Diabetes and pregnancy: perspectives from Asia. Diabet Med 2014; 31: 302-318.
9. Buckley BS, Harreiter J, Damm P, Corcoy R, Chico A, Simmons D et al. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med 2012; 29: 844-854.
10. IADPSG Consensus Panel. International Association of Diabetes and Pregnancy Study Group recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33: 676.
11. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25: 1862-1868.
12. Damm P, Kühl C, Buschard K, Jakobsen BK, Svejgaard A, Sodoyez-Goffaux F et al. Prevalence and predictive value of islet cell antibodies and insulin autoantibodies in women with gestational diabetes. Diabet Med 1994; 11: 558-563.
13. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2007; 92(8 Suppl): S1-47.
14. Stagnaro-Green A. Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab 2012; 97: 334.
15. De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 2543-2565.
16. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med 1995; 333: 1688-1694.
17. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011; 34(supplement 1): S11-S61.
18. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21: 1081-1125.
19. Soldin OP. Thyroid function testing in pregnancy and thyroid disease: trimester-specific reference intervals. Ther Drug Monit 2006; 28: 8-11.
20. Azizi F, Mehran L, Amouzegar A, Delshad H, Tohidi M, Askari S et al. Establishment of the trimester-specific reference range for free thyroxine index. Thyroid 2013; 23: 354-359.
21. Feely J. The physiology of thyroid function in pregnancy. Postgrad Med J 1979; 55: 336-339.
22. Brent GA. Maternal thyroid function: interpretation of thyroid function tests in pregnancy. Clin Obstet Gynecol 1997; 40: 3-15.
23. Moleti M, Trimarchi F, Vermiglio F. Thyroid Physiology in Pregnancy. Endocr Pract 2014; 21: 1-26.
24. Braverman L, Uitger RD (eds) Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text, 9th ed. NewYork: Lippincott Williams and Wilkins, 2005.
25. Scherbaum WA. On the clinical importance of thyroid microsomal and thyroglobulin antibody determination. Acta Endocrinol Suppl (Copenh). 1987; 281: 325-329.
26. Rosenbaum D, Davies TF. The clinical use of thyroid autoantibodies. Endocrinologist 1992; 2: 55-62.
27. Van den Boogaard E, Vissenberg R, Land JA, van Wely M, van der Post JA, Goddijn M et al. Significance of (sub) clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update 2011; 17: 605-619.
28. Nicholson WK, Robinson KA, Smallridge RC, Ladenson PW, Powe NR. Prevalence of postpartum thyroid dysfunction: a quantitative review. Thyroid 2006; 16: 573-582.
29. Shahbazian HB, Sarvghadi F, Azizi F. Prevalence and characteristics of postpartum thyroid dysfunction in Tehran. Eur J Endocrinol 2001; 145: 397-401.
30. Amino N, Tada H, Hidaka Y, Crapo LM, Stagnaro-Green A. Therapeutic controversy: Screening for postpartum thyroiditis. J Clin Endocrinol Metab 1999; 84: 1813-1821.
31. Premawardhana LD, Parkes AB, John R, Harris B, Lazarus JH. Thyroid peroxidase antibodies in early pregnancy: utility for prediction of postpartum thyroid dysfunction and implications for screening. Thyroid 2004; 14: 610-615.
32. Gerstein HC. Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus. Ann Intern Med 1993; 118: 419-423.
33. Alvarez-Marfany M, Roman SH, Drexler AJ, Robertson C, Stagnaro-Green A. Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1994; 79: 10-16.
34. Gallas PR, Stolk RP, Bakker K, Endert E, Wiersinga WM. Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type 1. Eur J Endocrinol 2002; 147: 443-451.
35. Agarwal MM, Dhatt GS, Punnose J, Bishawi B, Zayed R. Thyroid function abnormalities and anti-thyroid antibody prevalence in pregnant women at high risk for gestational diabetes mellitus. Gynecol Endocrinol 2006; 22: 261-266.
36. Azriel S, Camaño I, García-Burguillo A. Prevalence of antibodies to thyroid peroxidase (TPO) and postpartum thyroiditis (PPT) in a cohort of 1700 pregnant women with gestational diabetes mellitus (GDM). Endocrine Abstracts 2008; 16: P723.
37. Nøhr SB, Jørgensen A, Pedersen KM, Laurberg P. Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe? J Clin Endocrinol Metab 2000; 85: 3191.
38. Mazokopakis EE, Papadakis JA, Papadomanolaki MG, Batistakis AG, Giannakopoulos TG, Protopapadakis EE et al. Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis. Thyroid 2007; 17: 609.
39. Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007; 92: 1263.